Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

9 references·14 citing·39 second hop

FromToDepth

this work references cited by second hop

References

2013Diagnostic and Statistical Manual of Mental Disorders116,254 cited
2007The clinical global impressions scale: applying a research tool in clinical practice.1,969 cited
2017Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline1,517 cited
2007The Visual Scoring of Sleep in Adults1,063 cited
2018Digit Symbol Substitution Test834 cited
2014Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial519 cited
2010Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia379 cited
2012Orexin receptor antagonism for treatment of insomnia322 cited
2014Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials301 cited

Cited by

2020Pharmacological and non‐pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review141 cited
2020Pharmacotherapies for sleep disturbances in dementia128 cited
2023The orexin story and orexin receptor antagonists for the treatment of insomnia119 cited
2020Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

102 cited

2021The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis98 cited

2021Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies79 cited

2023Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations64 cited

2021The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer’s disease: a randomized, triple-blind, placebo-controlled trial47 cited

2020The Treatment of Sleep Dysfunction in Neurodegenerative Disorders46 cited

2020Comparative efficacy and safety of hypnotics for insomnia in older adults: a systematic review and network meta-analysis45 cited

2023Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches45 cited

2023A 2023 Update on Managing Insomnia in Primary Care44 cited

2022Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer’s Disease: A Structured Literature Review39 cited

2022Orexin Receptor Antagonists and Insomnia38 cited